William D. Turner
Corporate Officer/Principal bij VERA THERAPEUTICS, INC.
Actieve functies van William D. Turner
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
VERA THERAPEUTICS, INC. | Corporate Officer/Principal | 08-01-2023 | - |
Loopbaan van William D. Turner
Eerdere bekende functies van William D. Turner
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
SIERRA ONCOLOGY, INC. | Hoofd Techniek/Wetenschap/O&O | 04-08-2020 | 01-07-2022 |
AIMMUNE THERAPEUTICS, INC. | Corporate Officer/Principal | 01-07-2018 | 01-04-2020 |
Medimmune, Inc. | Algemeen Adviseur | - | - |
MedImmune Vaccines, Inc.
MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company is located in Mountain View, CA | Algemeen Adviseur | - | - |
DYNAVAX TECHNOLOGIES CORPORATION | Algemeen Adviseur | 01-08-2006 | - |
Opleiding van William D. Turner
The California State University | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 8 |
Operationeel
General Counsel | 3 |
Corporate Officer/Principal | 2 |
Undergraduate Degree | 1 |
Sectoraal
Health Technology | 7 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
DYNAVAX TECHNOLOGIES CORPORATION | Health Technology |
VERA THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
MedImmune Vaccines, Inc.
MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company is located in Mountain View, CA | Health Technology |
Sierra Oncology, Inc.
Sierra Oncology, Inc. BiotechnologyHealth Technology Sierra Oncology, Inc. was a clinical stage drug development company of therapeutics for the treatment of cancer. The firm focused on advanced targeted therapeutics for the treatment of patients with significant unmet medical needs in hematology and oncology. Its product Momelotinib, a selective and orally-bioavailable JAK1, JAK2 & ACVR1 inhibitor with a differentiated therapeutic profile in myelofibrosis encompassing robust constitutional symptom improvements. The company was founded in May 2003 and is headquartered in San Mateo, CA. | Health Technology |
Aimmune Therapeutics, Inc.
Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA. | Health Technology |
Medimmune, Inc. | Health Technology |
- Beurs
- Insiders
- William D. Turner
- Ervaring